160 related articles for article (PubMed ID: 26491313)
1. Biodegradation and cytotoxicity of ciprofloxacin-loaded hydroxyapatite-polycaprolactone nanocomposite film for sustainable bone implants.
Nithya R; Meenakshi Sundaram N
Int J Nanomedicine; 2015; 10 Suppl 1(Suppl 1):119-27. PubMed ID: 26491313
[TBL] [Abstract][Full Text] [Related]
2. Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering.
Fernandez JM; Molinuevo MS; Cortizo MS; Cortizo AM
J Tissue Eng Regen Med; 2011 Jun; 5(6):e126-35. PubMed ID: 21312338
[TBL] [Abstract][Full Text] [Related]
3. Hybrid hydroxyapatite nanoparticles-loaded PCL/GE blend fibers for bone tissue engineering.
Ba Linh NT; Min YK; Lee BT
J Biomater Sci Polym Ed; 2013; 24(5):520-38. PubMed ID: 23565865
[TBL] [Abstract][Full Text] [Related]
4. O2/Ar Plasma Treatment for Enhancing the Biocompatibility of Hydroxyapatite Nanopowder and Polycaprolactone Composite Film.
Ko YM; Myung SW; Kim BH
J Nanosci Nanotechnol; 2015 Aug; 15(8):6048-52. PubMed ID: 26369196
[TBL] [Abstract][Full Text] [Related]
5. Magnesium oxide nanoparticle-loaded polycaprolactone composite electrospun fiber scaffolds for bone-soft tissue engineering applications: in-vitro and in-vivo evaluation.
Suryavanshi A; Khanna K; Sindhu KR; Bellare J; Srivastava R
Biomed Mater; 2017 Sep; 12(5):055011. PubMed ID: 28944766
[TBL] [Abstract][Full Text] [Related]
6. Bioactivity assessment of PLLA/PCL/HAP electrospun nanofibrous scaffolds for bone tissue engineering.
Qi H; Ye Z; Ren H; Chen N; Zeng Q; Wu X; Lu T
Life Sci; 2016 Mar; 148():139-44. PubMed ID: 26874032
[TBL] [Abstract][Full Text] [Related]
7. In vitro study of hydroxyapatite/polycaprolactone (HA/PCL) nanocomposite synthesized by an in situ sol-gel process.
Rezaei A; Mohammadi MR
Mater Sci Eng C Mater Biol Appl; 2013 Jan; 33(1):390-6. PubMed ID: 25428086
[TBL] [Abstract][Full Text] [Related]
8. Mechanical properties and cytotoxicity of nanoplate-like hydroxyapatite/polylactide nanocomposites prepared by intercalation technique.
Wan Y; Wu C; Xiong G; Zuo G; Jin J; Ren K; Zhu Y; Wang Z; Luo H
J Mech Behav Biomed Mater; 2015 Jul; 47():29-37. PubMed ID: 25837342
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyapatite-TiO(2)-based nanocomposites synthesized in supercritical CO(2) for bone tissue engineering: physical and mechanical properties.
Salarian M; Xu WZ; Wang Z; Sham TK; Charpentier PA
ACS Appl Mater Interfaces; 2014 Oct; 6(19):16918-31. PubMed ID: 25184699
[TBL] [Abstract][Full Text] [Related]
10. Biomaterial-Based Nanocomposite for Osteogenic Repurposing of Doxycycline.
El-Habashy S; Eltaher H; Gaballah A; Mehanna R; El-Kamel AH
Int J Nanomedicine; 2021; 16():1103-1126. PubMed ID: 33603371
[TBL] [Abstract][Full Text] [Related]
11. Polycaprolactone/hydroxyapatite composite scaffolds: preparation, characterization, and in vitro and in vivo biological responses of human primary bone cells.
Chuenjitkuntaworn B; Inrung W; Damrongsri D; Mekaapiruk K; Supaphol P; Pavasant P
J Biomed Mater Res A; 2010 Jul; 94(1):241-51. PubMed ID: 20166220
[TBL] [Abstract][Full Text] [Related]
12. PCL-coated hydroxyapatite scaffold derived from cuttlefish bone: morphology, mechanical properties and bioactivity.
Milovac D; Gallego Ferrer G; Ivankovic M; Ivankovic H
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():437-45. PubMed ID: 24268280
[TBL] [Abstract][Full Text] [Related]
13. Osteoinduction and proliferation of bone-marrow stromal cells in three-dimensional poly (ε-caprolactone)/ hydroxyapatite/collagen scaffolds.
Wang T; Yang X; Qi X; Jiang C
J Transl Med; 2015 May; 13():152. PubMed ID: 25952675
[TBL] [Abstract][Full Text] [Related]
14. Osteoblastic phenotype expression of MC3T3-E1 cultured on electrospun polycaprolactone fiber mats filled with hydroxyapatite nanoparticles.
Wutticharoenmongkol P; Pavasant P; Supaphol P
Biomacromolecules; 2007 Aug; 8(8):2602-10. PubMed ID: 17655356
[TBL] [Abstract][Full Text] [Related]
15. Does translational symmetry matter on the micro scale? Fibroblastic and osteoblastic interactions with the topographically distinct poly(ε-caprolactone)/hydroxyapatite thin films.
Uskoković V; Desai TA
ACS Appl Mater Interfaces; 2014 Aug; 6(15):13209-20. PubMed ID: 25014232
[TBL] [Abstract][Full Text] [Related]
16. RGD-conjugated copolymer incorporated into composite of poly(lactide-co-glycotide) and poly(L-lactide)-grafted nanohydroxyapatite for bone tissue engineering.
Zhang P; Wu H; Wu H; Lù Z; Deng C; Hong Z; Jing X; Chen X
Biomacromolecules; 2011 Jul; 12(7):2667-80. PubMed ID: 21604718
[TBL] [Abstract][Full Text] [Related]
17. Improvement of dual-leached polycaprolactone porous scaffolds by incorporating with hydroxyapatite for bone tissue regeneration.
Thadavirul N; Pavasant P; Supaphol P
J Biomater Sci Polym Ed; 2014; 25(17):1986-2008. PubMed ID: 25291106
[TBL] [Abstract][Full Text] [Related]
18. Long-term in vitro degradation behavior and biocompatibility of polycaprolactone/cobalt-substituted hydroxyapatite composite for bone tissue engineering.
Lin WC; Yao C; Huang TY; Cheng SJ; Tang CM
Dent Mater; 2019 May; 35(5):751-762. PubMed ID: 30857736
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical characterization and in vivo evaluation of triamcinolone acetonide-loaded hydroxyapatite nanocomposites for treatment of rheumatoid arthritis.
Jafari S; Maleki-Dizaji N; Barar J; Barzegar-Jalali M; Rameshrad M; Adibkia K
Colloids Surf B Biointerfaces; 2016 Apr; 140():223-232. PubMed ID: 26764105
[TBL] [Abstract][Full Text] [Related]
20. Hot melt poly-ε-caprolactone/poloxamine implantable matrices for sustained delivery of ciprofloxacin.
Puga AM; Rey-Rico A; Magariños B; Alvarez-Lorenzo C; Concheiro A
Acta Biomater; 2012 Apr; 8(4):1507-18. PubMed ID: 22251935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
